Ancora Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ancora Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Sell	660 -136	-17%	-$18.4K	﹤0.01%	888
2026 Q1	$102K	Buy	796 +16	+2%	+$2K	﹤0.01%	902
2025 Q4	$95.1K	Buy	780 +123	+19%	+$14.1K	﹤0.01%	928
2025 Q3	$65.8K	Hold	657	–	–	﹤0.01%	969
2025 Q2	$54.5K	Hold	657	–	–	﹤0.01%	1005
2025 Q1	$53.3K	Hold	657	–	–	﹤0.01%	1003
2024 Q4	$59.2K	Sell	657 -241	-27%	-$23.3K	﹤0.01%	967
2024 Q3	$88.7K	Hold	898	–	–	﹤0.01%	854
2024 Q2	$83.3K	Sell	898 -600	-40%	-$53.8K	﹤0.01%	838
2024 Q1	$142K	Buy	1,498 +9	+0.6%	+$835	﹤0.01%	749
2023 Q4	$133K	Sell	1,489 -167	-10%	-$12.4K	﹤0.01%	753
2023 Q3	$121K	Sell	1,656 -127	-7%	-$10.1K	﹤0.01%	755
2023 Q2	$148K	Hold	1,783	–	–	﹤0.01%	714
2023 Q1	$136K	Hold	1,783	–	–	﹤0.01%	719
2022 Q4	$148K	Buy	1,783 +311	+21%	+$25.2K	﹤0.01%	738
2022 Q3	$117K	Hold	1,472	–	–	﹤0.01%	854
2022 Q2	$109K	Buy	1,472 +1,162	+375%	+$87.2K	﹤0.01%	938
2022 Q1	$28K	Sell	310 -22	-7%	-$2.03K	﹤0.01%	1458
2021 Q4	$37K	Buy	332 +84	+34%	+$10.1K	﹤0.01%	1384
2021 Q3	$31K	Buy	248 +117	+89%	+$15.1K	﹤0.01%	1341
2021 Q2	$18K	Sell	131 -360	-73%	-$47.3K	﹤0.01%	1383
2021 Q1	$67K	Sell	491 -154	-24%	-$23.1K	﹤0.01%	977
2020 Q4	$91K	Buy	645 +40	+7%	+$5.12K	﹤0.01%	768
2020 Q3	$67K	Buy	605 +356	+143%	+$39.9K	﹤0.01%	800
2020 Q2	$28K	Buy	249 +41	+20%	+$4.04K	﹤0.01%	933
2020 Q1	$16K	Buy	208 +113	+119%	+$10K	﹤0.01%	1098
2019 Q4	$9K	Buy	+95	New	+$8.22K	﹤0.01%	1191
2017 Q1	–	Sell	-15	Closed	-$1K	–	1080
2016 Q4	$1K	Buy	+15	New	+$926	﹤0.01%	1215

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Ancora Advisors's XBI Position: Q2 2026 in Review

Ancora Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 17% in Q2 2026, selling an estimated $18.4K and leaving 660 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Ancora Advisors first reported a position in XBI in Q4 2016 and has held it in 28 quarters since. The position peaked at $148K in Q2 2023. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Ancora Advisors held 660 shares of State Street SPDR S&P Biotech ETF worth $104K as of Q2 2026.
Ancora Advisors sold 136 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $18.4K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #888 holding.
Ancora Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 28 quarters since.
Ancora Advisors's State Street SPDR S&P Biotech ETF position peaked at $148K in Q2 2023.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.